Neil Stahl
Regeneron Pharmaceuticals
Executive Vice President, Research & Development
Overview
Neil Stahl made an average of $7.6M in compensation at Regeneron Pharmaceuticals from 2006 to 2015.
Annual data
2015
In 2015, Neil Stahl earned a total compensation of $18.4M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals.
| Ranking | 142 out of 13,574 |
|---|---|
| Percentile | 99.0% |
Neil Stahl's 2015 compensation ranked 142nd out of 13,574 executive pay records tracked by us this year.
Stahl earned more than 99.0% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 21 out of 1,484 |
| Percentile | 98.6% |
In the industry group of Drugs, Stahl's pay ranked 21st out of 1,484 executive pay records tracked by us in 2015.
Stahl earned more than 98.6% of executives in this group.
| Bonus | $594,000 |
|---|---|
| Option Awards | $17,209,995 |
| Salary | $550,000 |
| Other | $20,515 |
| Total | $18,374,510 |
Stahl received $17.2M in option awards, which accounts for 93.66% of total compensation.
Stahl also received $594K in bonus, $550K in salary and $20.5K in other compensation.
2014
In 2014, Neil Stahl earned a total compensation of $16.3M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals.
| Ranking | 195 out of 12,876 |
|---|---|
| Percentile | 98.5% |
Neil Stahl's 2014 compensation ranked 195th out of 12,876 executive pay records tracked by us this year.
Stahl earned more than 98.5% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 24 out of 1,310 |
| Percentile | 98.2% |
In the industry group of Drugs, Stahl's pay ranked 24th out of 1,310 executive pay records tracked by us in 2014.
Stahl earned more than 98.2% of executives in this group.
| Bonus | $532,980 |
|---|---|
| Option Awards | $15,207,420 |
| Salary | $493,500 |
| Other | $20,215 |
| Total | $16,254,115 |
Stahl received $15.2M in option awards, which accounts for 93.56% of total compensation.
Stahl also received $533K in bonus, $493.5K in salary and $20.2K in other compensation.
2013
In 2013, Neil Stahl earned a total compensation of $14.4M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals.
| Ranking | 194 out of 11,965 |
|---|---|
| Percentile | 98.4% |
Neil Stahl's 2013 compensation ranked 194th out of 11,965 executive pay records tracked by us this year.
Stahl earned more than 98.4% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 11 out of 1,095 |
| Percentile | 99.0% |
In the industry group of Drugs, Stahl's pay ranked 11th out of 1,095 executive pay records tracked by us in 2013.
Stahl earned more than 99.0% of executives in this group.
| Bonus | $386,208 |
|---|---|
| Option Awards | $13,474,403 |
| Salary | $476,800 |
| Other | $17,235 |
| Total | $14,354,646 |
Stahl received $13.5M in option awards, which accounts for 93.87% of total compensation.
Stahl also received $386.2K in bonus, $476.8K in salary and $17.2K in other compensation.
2012
In 2012, Neil Stahl earned a total compensation of $12M as Executive Vice President, Research & Development at Regeneron Pharmaceuticals.
| Ranking | 290 out of 10,949 |
|---|---|
| Percentile | 97.4% |
Neil Stahl's 2012 compensation ranked 290th out of 10,949 executive pay records tracked by us this year.
Stahl earned more than 97.4% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 12 out of 850 |
| Percentile | 98.6% |
In the industry group of Drugs, Stahl's pay ranked 12th out of 850 executive pay records tracked by us in 2012.
Stahl earned more than 98.6% of executives in this group.
| Bonus | $373,167 |
|---|---|
| Option Awards | $11,144,533 |
| Salary | $460,700 |
| Other | $16,800 |
| Total | $11,995,200 |
Stahl received $11.1M in option awards, which accounts for 92.91% of total compensation.
Stahl also received $373.2K in bonus, $460.7K in salary and $16.8K in other compensation.
2011
In 2011, Neil Stahl earned a total compensation of $3.2M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 1,952 out of 10,038 |
|---|---|
| Percentile | 80.6% |
Neil Stahl's 2011 compensation ranked 1,952nd out of 10,038 executive pay records tracked by us this year.
Stahl earned more than 80.6% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 89 out of 705 |
| Percentile | 87.4% |
In the industry group of Drugs, Stahl's pay ranked 89th out of 705 executive pay records tracked by us in 2011.
Stahl earned more than 87.4% of executives in this group.
| Bonus | $360,531 |
|---|---|
| Option Awards | $2,328,187 |
| Salary | $445,100 |
| Other | $16,420 |
| Total | $3,150,238 |
Stahl received $2.3M in option awards, which accounts for 73.91% of total compensation.
Stahl also received $360.5K in bonus, $445.1K in salary and $16.4K in other compensation.
2010
In 2010, Neil Stahl earned a total compensation of $4.5M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 1,137 out of 9,480 |
|---|---|
| Percentile | 88.0% |
Neil Stahl's 2010 compensation ranked 1,137th out of 9,480 executive pay records tracked by us this year.
Stahl earned more than 88.0% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 54 out of 619 |
| Percentile | 91.3% |
In the industry group of Drugs, Stahl's pay ranked 54th out of 619 executive pay records tracked by us in 2010.
Stahl earned more than 91.3% of executives in this group.
| Bonus | $340,560 |
|---|---|
| Option Awards | $2,204,850 |
| Salary | $430,000 |
| Stock Awards | $1,531,500 |
| Other | $13,540 |
| Total | $4,520,450 |
Stahl received $2.2M in option awards, which accounts for 48.78% of total compensation.
Stahl also received $340.6K in bonus, $430K in salary, $1.5M in stock awards and $13.5K in other compensation.
2009
In 2009, Neil Stahl earned a total compensation of $2.9M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 1,521 out of 8,716 |
|---|---|
| Percentile | 82.5% |
Neil Stahl's 2009 compensation ranked 1,521st out of 8,716 executive pay records tracked by us this year.
Stahl earned more than 82.5% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 72 out of 583 |
| Percentile | 87.7% |
In the industry group of Drugs, Stahl's pay ranked 72nd out of 583 executive pay records tracked by us in 2009.
Stahl earned more than 87.7% of executives in this group.
| Bonus | $1,081,088 |
|---|---|
| Option Awards | $1,382,430 |
| Salary | $390,400 |
| Other | $13,540 |
| Total | $2,867,458 |
Stahl received $1.4M in option awards, which accounts for 48.21% of total compensation.
Stahl also received $1.1M in bonus, $390.4K in salary and $13.5K in other compensation.
2008
In 2008, Neil Stahl earned a total compensation of $1.1M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 3,621 out of 7,736 |
|---|---|
| Percentile | 53.2% |
Neil Stahl's 2008 compensation ranked 3,621st out of 7,736 executive pay records tracked by us this year.
Stahl earned more than 53.2% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 161 out of 542 |
| Percentile | 70.3% |
In the industry group of Drugs, Stahl's pay ranked 161st out of 542 executive pay records tracked by us in 2008.
Stahl earned more than 70.3% of executives in this group.
| Bonus | $208,450 |
|---|---|
| Option Awards | $501,985 |
| Salary | $379,000 |
| Other | $12,745 |
| Total | $1,102,180 |
Stahl received $502K in option awards, which accounts for 45.54% of total compensation.
Stahl also received $208.5K in bonus, $379K in salary and $12.7K in other compensation.
2007
In 2007, Neil Stahl earned a total compensation of $2M as Senior Vice President, Research & Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 2,000 out of 6,999 |
|---|---|
| Percentile | 71.4% |
Neil Stahl's 2007 compensation ranked 2,000th out of 6,999 executive pay records tracked by us this year.
Stahl earned more than 71.4% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 79 out of 467 |
| Percentile | 83.1% |
In the industry group of Drugs, Stahl's pay ranked 79th out of 467 executive pay records tracked by us in 2007.
Stahl earned more than 83.1% of executives in this group.
| Bonus | $291,000 |
|---|---|
| Option Awards | $1,365,898 |
| Salary | $364,100 |
| Other | $11,985 |
| Total | $2,032,983 |
Stahl received $1.4M in option awards, which accounts for 67.19% of total compensation.
Stahl also received $291K in bonus, $364.1K in salary and $12K in other compensation.
2006
In 2006, Neil Stahl earned a total compensation of $1.3M as Senior Vice President, Research Development Sciences at Regeneron Pharmaceuticals.
| Ranking | 1,985 out of 5,372 |
|---|---|
| Percentile | 63.0% |
Neil Stahl's 2006 compensation ranked 1,985th out of 5,372 executive pay records tracked by us this year.
Stahl earned more than 63.0% of all executives tracked by us in 2018.
| Industry group | Drugs |
|---|---|
| Ranking | 76 out of 431 |
| Percentile | 82.4% |
In the industry group of Drugs, Stahl's pay ranked 76th out of 431 executive pay records tracked by us in 2006.
Stahl earned more than 82.4% of executives in this group.
| Bonus | $171,000 |
|---|---|
| Option Awards | $796,890 |
| Salary | $348,400 |
| Other | $11,755 |
| Total | $1,328,045 |
Stahl received $796.9K in option awards, which accounts for 60.00% of total compensation.
Stahl also received $171K in bonus, $348.4K in salary and $11.8K in other compensation.